BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rathore AP, Mantri CK, Aman SA, Syenina A, Ooi J, Jagaraj CJ, Goh CC, Tissera H, Wilder-Smith A, Ng LG, Gubler DJ, St John AL. Dengue virus-elicited tryptase induces endothelial permeability and shock. J Clin Invest 2019;129:4180-93. [PMID: 31265436 DOI: 10.1172/JCI128426] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Trung DT, Trieu HT, Wills BA. Microvascular Fluid Exchange: Implications of the Revised Starling Model for Resuscitation of Dengue Shock Syndrome. Front Med (Lausanne) 2020;7:601520. [PMID: 33415117 DOI: 10.3389/fmed.2020.601520] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Syenina A, Saron WAA, Jagaraj CJ, Bibi S, Arock M, Gubler DJ, Rathore APS, Abraham SN, St John AL. Th1-Polarized, Dengue Virus-Activated Human Mast Cells Induce Endothelial Transcriptional Activation and Permeability. Viruses 2020;12:E1379. [PMID: 33276578 DOI: 10.3390/v12121379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Byrne AB, García AG, Brahamian JM, Mauri A, Ferretti A, Polack FP, Talarico LB. A murine model of dengue virus infection in suckling C57BL/6 and BALB/c mice. Animal Model Exp Med 2021;4:16-26. [PMID: 33738433 DOI: 10.1002/ame2.12145] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wu ML, Liu FL, Sun J, Li X, He XY, Zheng HY, Zhou YH, Yan Q, Chen L, Yu GY, Chang J, Jin X, Zhao J, Chen XW, Zheng YT, Wang JH. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduct Target Ther 2021;6:428. [PMID: 34921131 DOI: 10.1038/s41392-021-00849-0] [Reference Citation Analysis]
5 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Malavige GN, Jeewandara C, Ogg GS. Dysfunctional Innate Immune Responses and Severe Dengue. Front Cell Infect Microbiol 2020;10:590004. [PMID: 33194836 DOI: 10.3389/fcimb.2020.590004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Li X, Peng T. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery. Front Pharmacol 2021;12:660710. [PMID: 34017257 DOI: 10.3389/fphar.2021.660710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 King CA, Wegman AD, Endy TP. Mobilization and Activation of the Innate Immune Response to Dengue Virus. Front Cell Infect Microbiol 2020;10:574417. [PMID: 33224897 DOI: 10.3389/fcimb.2020.574417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Karimi N, Morovati S, Chan L, Napoleoni C, Mehrani Y, Bridle BW, Karimi K. Mast Cell Tryptase and Implications for SARS-CoV-2 Pathogenesis. BioMed 2021;1:136-49. [DOI: 10.3390/biomed1020013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rathore AP, St John AL. Protective and pathogenic roles for mast cells during viral infections. Curr Opin Immunol 2020;66:74-81. [PMID: 32563779 DOI: 10.1016/j.coi.2020.05.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
11 Ghali GZ, Ghali MGZ. Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia. Neural Regen Res 2020;15:2217-34. [PMID: 32594033 DOI: 10.4103/1673-5374.284981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Silva T, Jeewandara C, Gomes L, Gangani C, Mahapatuna SD, Pathmanathan T, Wijewickrama A, Ogg GS, Malavige GN. Urinary leukotrienes and histamine in patients with varying severity of acute dengue. PLoS One 2021;16:e0245926. [PMID: 33544746 DOI: 10.1371/journal.pone.0245926] [Reference Citation Analysis]
13 Mantri CK, Soundarajan G, Saron WAA, Rathore APS, Alonso S, St John AL. Maternal Immunity and Vaccination Influence Disease Severity in Progeny in a Novel Mast Cell-Deficient Mouse Model of Severe Dengue. Viruses 2021;13:900. [PMID: 34066286 DOI: 10.3390/v13050900] [Reference Citation Analysis]
14 Teo A, Chua CLL, Chia PY, Yeo TW. Insights into potential causes of vascular hyperpermeability in dengue. PLoS Pathog 2021;17:e1010065. [PMID: 34882753 DOI: 10.1371/journal.ppat.1010065] [Reference Citation Analysis]
15 Richardson-Boedler C. Dengue Shock Syndrome: Its Similarity with Anaphylaxis and with the Homeopathic Medicine Apis mellifica (European Honeybee). Homeopathy 2021. [PMID: 34749419 DOI: 10.1055/s-0041-1734027] [Reference Citation Analysis]
16 Marshall JS, Portales-Cervantes L, Leong E. Mast Cell Responses to Viruses and Pathogen Products. Int J Mol Sci 2019;20:E4241. [PMID: 31480219 DOI: 10.3390/ijms20174241] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 15.7] [Reference Citation Analysis]
17 St John AL, Rathore APS, Ginhoux F. New perspectives on the origins and heterogeneity of mast cells. Nat Rev Immunol 2022. [PMID: 35610312 DOI: 10.1038/s41577-022-00731-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang YN, Zhang YF, Peng XF, Ge HH, Wang G, Ding H, Li Y, Li S, Zhang LY, Zhang JT, Li H, Zhang XA, Liu W. Mast Cell-Derived Proteases Induce Endothelial Permeability and Vascular Damage in Severe Fever with Thrombocytopenia Syndrome. Microbiol Spectr 2022;:e0129422. [PMID: 35612327 DOI: 10.1128/spectrum.01294-22] [Reference Citation Analysis]
19 Durbin AP. Dengue vascular leak syndrome: insights into potentially new treatment modalities. J Clin Invest 2019;129:4072-3. [PMID: 31449055 DOI: 10.1172/JCI131170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Puerta-guardo H, Biering SB, de Sousa FTG, Shu J, Glasner DR, Li J, Blanc SF, Beatty PR, Harris E. Flavivirus NS1 Triggers Tissue-Specific Disassembly of Intercellular Junctions Leading to Barrier Dysfunction and Vascular Leak in a GSK-3β-Dependent Manner. Pathogens 2022;11:615. [DOI: 10.3390/pathogens11060615] [Reference Citation Analysis]
21 Rodrigo C, Sigera C, Fernando D, Rajapakse S. Plasma leakage in dengue: a systematic review of prospective observational studies. BMC Infect Dis 2021;21:1082. [PMID: 34670495 DOI: 10.1186/s12879-021-06793-2] [Reference Citation Analysis]
22 Ghali GZ, Ghali MGZ. β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma. Mol Biol Rep 2020;47:4631-50. [PMID: 32303958 DOI: 10.1007/s11033-020-05427-1] [Reference Citation Analysis]
23 Sahin M, Remy MM, Merkler D, Pinschewer DD. The Janus Kinase Inhibitor Ruxolitinib Prevents Terminal Shock in a Mouse Model of Arenavirus Hemorrhagic Fever. Microorganisms 2021;9:564. [PMID: 33803310 DOI: 10.3390/microorganisms9030564] [Reference Citation Analysis]
24 Fosse JH, Haraldsen G, Falk K, Edelmann R. Endothelial Cells in Emerging Viral Infections. Front Cardiovasc Med 2021;8:619690. [PMID: 33718448 DOI: 10.3389/fcvm.2021.619690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
25 Jiang L, Lu C, Sun Q. Tree Shrew as a New Animal Model for the Study of Dengue Virus. Front Immunol 2021;12:621164. [PMID: 33841402 DOI: 10.3389/fimmu.2021.621164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Yan Y, Yang J, Xiao D, Yin J, Song M, Xu Y, Zhao L, Dai Q, Li Y, Wang C, Wang Z, Ren X, Yang X, Ni J, Liu M, Guo X, Li W, Chen X, Liu Z, Cao R, Zhong W. Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins. Antiviral Res 2022;:105325. [PMID: 35460703 DOI: 10.1016/j.antiviral.2022.105325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Losada PX, DeLaura I, Narváez CF. Dengue Virus and Platelets: From the Biology to the Clinic. Viral Immunol 2022. [PMID: 35483090 DOI: 10.1089/vim.2021.0135] [Reference Citation Analysis]